During the past decade, Internal Medicine Associates of Bozeman conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Internal Medicine Associates of Bozeman" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Eastern Cooperative Oncology Group" with 2 trials sponsored and "GOG Foundation" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Internal Medicine Associates of Bozeman" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Internal Medicine Associates of Bozeman" are "Breast Cancer" (3 trials), "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (1 trials), "Adenocarcinoma of the Colon" (1 trials), "Adult Acute Lymphoblastic Leukemia in Remission" (1 trials) and "Adult Acute Megakaryoblastic Leukemia" (1 trials). Many other conditions were trialed in "Internal Medicine Associates of Bozeman" in a lesser frequency.

Most popular intervention types in "Internal Medicine Associates of Bozeman" are "Drug" (18 trials), "Biological" (7 trials), "Other" (7 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "cyclophosphamide" (3 trials), "filgrastim" (3 trials), "Imatinib Mesylate" (2 trials) and "cetuximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Internal Medicine Associates of Bozeman" are 15 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Internal Medicine Associates of Bozeman". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Internal Medicine Associates of Bozeman, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Internal Medicine Associates of Bozeman, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".